Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM07U5R)

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Investigative Drug(s)

Approved Drug(s)

Clinical Trial Drug(s)

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Diacylglycerol lipase alpha (DAGLA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
RHC80267	DMC471Z	Discovery agent	N.A.	Investigative	[2]
------------------------------------------------------------------------------------

Drug(s) Targeting Fatty acid amide hydrolase (FAAH)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Propofol	DMB4OLE	Anaesthesia	9A78.6	Approved	[3]
Thiopental	DMGP8AX	Anaesthesia	9A78.6	Approved	[4]
JNJ-42165279	DM72GZO	Anxiety disorder	6B00-6B0Z	Phase 2	[5]
SSR411298	DMGTB2Q	Major depressive disorder	6A70.3	Phase 2	[6]
IW-6118	DMP42W1	Inflammation	1A00-CA43.1	Phase 2	[7]
PF-04457845	DMPRYU1	Liver disease	DB90-BD99	Phase 2	[8]
IPI-940	DMEIM5G	Pain	MG30-MG3Z	Phase 1	[9]
PMID29053063-Compound-11d	DMDRK68	N. A.	N. A.	Patented	[1]
Piperazine carbamic compound 1	DMZSYU4	N. A.	N. A.	Patented	[1]
Piperazine carbamic compound 2	DMMQ0ZO	N. A.	N. A.	Patented	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Drug(s) Targeting Monoglyceride lipase (MAGL)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ABX-1431	DM9SYVJ	Neuropathic pain	8E43.0	Phase 1	[10]
PMID29053063-Compound-11d	DMDRK68	N. A.	N. A.	Patented	[1]
Piperazine carbamic compound 1	DMZSYU4	N. A.	N. A.	Patented	[1]
Piperazine carbamic compound 2	DMMQ0ZO	N. A.	N. A.	Patented	[1]
Pyrazole derivative 82	DMETCI3	N. A.	N. A.	Patented	[1]
Pyrazole derivative 81	DMWT437	N. A.	N. A.	Patented	[1]
Pyrazole derivative 80	DMQ3TGM	N. A.	N. A.	Patented	[1]
Carbamide derivative 24	DMD6Y73	N. A.	N. A.	Patented	[1]
Piperazine carbamic compound 4	DMKZUO4	N. A.	N. A.	Patented	[1]
Carbamide derivative 26	DMDU9XF	N. A.	N. A.	Patented	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Diacylglycerol lipase alpha (DAGLA)	TTRQ6UD	DGLA_HUMAN	Inhibitor	[1]
Fatty acid amide hydrolase (FAAH)	TTDP1UC	NOUNIPROTAC	Inhibitor	[1]
Monoglyceride lipase (MAGL)	TTZ963I	MGLL_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	A patent review of Monoacylglycerol Lipase (MAGL) inhibitors (2013-2017).Expert Opin Ther Pat. 2017 Dec;27(12):1341-1351.
2	Assay and inhibition of diacylglycerol lipase activity. Bioorg Med Chem Lett. 2012 Jul 15;22(14):4585-92.
3	Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17.
4	The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase. Br J Pharmacol. 2003 Jul;139(5):1005-13.
5	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
6	Pharma & Vaccines. Product Development Pipeline. April 29 2009.
7	The Discovery and Development of Inhibitors of Fatty Acid Amide Hydrolase (FAAH). Bioorg Med Chem Lett. 2011 August 15; 21(16): 4674-4685.
8	Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor. ACS Med Chem Lett. 2011 Feb 10;2(2):91-96.
9	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1400).
10	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)